Recombinant Human TRAIL/TNFSF10 (E. coli-expressed) Protein
Catalog # 375-TEC | R&D Systems, Inc. a Bio-Techne Brand
Loading...
Key Product Details
Source: | E. coli |
Accession #: | Q6IBA9 |
Structure / Form: | Homotrimer |
Applications: | Bioactivity |
Citations for Recombinant Human TRAIL/TNFSF10 (E. coli-expressed) Protein (11)
Showing
1
-
10 of
11 citations
Showing All
Filter By:
Search Title:
Citations are publications that use Bio-Techne products. Selected citations for Recombinant Human TRAIL/TNFSF10 (E. coli-expressed) Protein include:
-
Species: Human
Sample Types: Whole Cells
Applications: BioassayM Frank-Bert et al. (2018-01-29), TLR3 Ligand Poly(I:C) Exerts Distinct Actions in Synovial Fibroblasts When Delivered by Extracellular Vesicles Front Immunol, 2018-09(0):28.
PMID: 29434584 -
Species: Human
Sample Types: Whole Cells
Applications: BioassayV Zoller et al. (2017-07-18), Trail (TNF-related apoptosis-inducing ligand) induces an inflammatory response in human adipocytes Sci Rep, 2017-07(1):5691.
PMID: 28720906 -
Species: Human
Sample Types: Whole Cells
Applications: Bioassay(2016-11-18), Endotoxemia contributes to CD27+ memory B-cell apoptosis via enhanced sensitivity to Fas ligation in patients with Cirrhosis Sci Rep, 2016-16(0):36862.
PMID: 27857173 -
Species: Human
Sample Types: Whole Cells
Applications: CAR-T (Bioassay)Roybal K et al. (2016-09-29), Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors. Cell, 2016-0167(2):419-432.e16.
PMID: 27693353 -
Species: Human
Sample Types: Whole Cells
Applications: BioassayBozza et al. (2014-09-04), The use of a stably expressed FRET biosensor for determining the potency of cancer drugs. PLoS ONE, 2014-09(9):e107010.
PMID: 25188024 -
Species: Human
Sample Types: Whole Cells
Applications: BioassayGuicciardi et al. (2014-03-14), Cellular inhibitor of apoptosis (cIAP)-mediated ubiquitination of phosphofurin acidic cluster sorting protein 2 (PACS-2) negatively regulates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity. PLoS ONE, 2014-09(3):e92124.
PMID: 24633224 -
Species: Human
Sample Types: Whole Cells
Applications: BioassayPark SJ et al. (2009-04-28), Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP. Biochem. J., 2009-0420(1):73-81.
PMID: 19203346 -
Species: Human
Sample Types: Whole Cells
Applications: BioassayRoux S et al. (2005-07-22), Death receptors, Fas and TRAIL receptors, are involved in human osteoclast apoptosis. Biochem. Biophys. Res. Commun., 2005-0333(1):42-50.
PMID: 15936719 -
Species: Human
Sample Types: Whole Cells
Applications: BioassayChopin V et al. (2004-08-15), Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1). Exp. Cell Res., 2004-0298(2):560-73.
PMID: 15265702 -
Sample Types: Whole Cells
Applications: BioassayRyan LA et al. (2004-03-01), TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia. J. Neuroimmunol., 2004-0148(1):127-39.
PMID: 14975593 -
Species: Human, Mouse
Sample Types: Whole Cells
Applications: BioassaySade H et al. (2003-10-28), The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells. J. Biol. Chem., 2003-1279(4):2937-44.
PMID: 14583609
There are no citations that match your criteria.